Sterling IMRES
Sign in
Research articleOpen access

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine · 31 December 2020

Read at the publisher Full text on PMC
Reference library record. This work was written and published by the people and publisher named here. It is listed in the Sterling IMRES reference library for study and citation. Sterling IMRES did not author or publish it, and listing a work does not mean its authors are affiliated with the institute. Metadata verified via Crossref. How records are verified

Summary

Reports safety and efficacy results from the pivotal placebo-controlled trial of the BNT162b2 mRNA COVID-19 vaccine. The data supported the vaccine's emergency authorization and marked the first large-scale clinical demonstration of an mRNA vaccine platform.

Summary written by Sterling IMRES editors. Read the original abstract at the publisher.

Authors

The full author list is available from the publisher.

Cite this work

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine. 2020;383(27):2603-2615. doi:10.1056/NEJMoa2034577

Related publications